Corebridge Financial Inc. has slightly lowered its stake in Ingevity Corporation, selling 372 shares during the first quarter. The investment firm now holds 19,016 shares of the NYSE-listed specialty chemicals producer, according to its recent filing with the Securities and Exchange Commission.

Corebridge Financial Inc. has slightly trimmed its stake in Astrana Health, selling 436 shares during the first quarter. The move, revealed in a recent SEC filing, reduces the institutional investor’s position by 1.9% and leaves it with a total of 22,454 shares.